Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
21 août 2024 17h00 HE
|
Cytek Biosciences, Inc.
Cytek announced that its San Diego reagent manufacturing facility has been awarded EN ISO 13485:2016 Quality Management System (QMS) certification.
Cytek Biosciences to Participate in Upcoming Investor Conferences
08 août 2024 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences Reports Second Quarter 2024 Financial Results
06 août 2024 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
30 juil. 2024 17h00 HE
|
Cytek Biosciences, Inc.
Cytek has developed a revolutionary tool to automate panel design. SpectroPanel is an intelligent algorithm that suggests optimized panels in minutes.
Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
30 juil. 2024 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the second...
Cytek Biosciences Announces $50 Million Stock Repurchase Program
06 juin 2024 08h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved the...
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
30 mai 2024 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming...
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
28 mai 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received China NMPA approval for for clinical diagnostic use.
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
20 mai 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek has announced its Enhanced Small Particle Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
Cytek Biosciences Reports First Quarter 2024 Financial Results
08 mai 2024 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...